ATE404558T1 - Antimikrobielle 4-oxochinolizinverbindungen, die als teilstruktur ein 2-pyridonskelett aufweisen - Google Patents

Antimikrobielle 4-oxochinolizinverbindungen, die als teilstruktur ein 2-pyridonskelett aufweisen

Info

Publication number
ATE404558T1
ATE404558T1 AT02775254T AT02775254T ATE404558T1 AT E404558 T1 ATE404558 T1 AT E404558T1 AT 02775254 T AT02775254 T AT 02775254T AT 02775254 T AT02775254 T AT 02775254T AT E404558 T1 ATE404558 T1 AT E404558T1
Authority
AT
Austria
Prior art keywords
halo
oxocinolicine
antimicrobial
compounds
oxoquinolizine
Prior art date
Application number
AT02775254T
Other languages
English (en)
Inventor
Ryoichi Fukumoto
Yoshimi Niwano
Hiroyuki Kusakabe
Chong Chu
Hiroaki Kimura
Koh Nagasawa
Satoshi Yanagihara
Chisato Hirosawa
Seiji Ishiduka
Original Assignee
Sato Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sato Pharma filed Critical Sato Pharma
Application granted granted Critical
Publication of ATE404558T1 publication Critical patent/ATE404558T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02775254T 2001-09-28 2002-09-27 Antimikrobielle 4-oxochinolizinverbindungen, die als teilstruktur ein 2-pyridonskelett aufweisen ATE404558T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001299088 2001-09-28
JP2001326133 2001-10-24

Publications (1)

Publication Number Publication Date
ATE404558T1 true ATE404558T1 (de) 2008-08-15

Family

ID=26623198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02775254T ATE404558T1 (de) 2001-09-28 2002-09-27 Antimikrobielle 4-oxochinolizinverbindungen, die als teilstruktur ein 2-pyridonskelett aufweisen

Country Status (6)

Country Link
US (1) US7223773B2 (de)
EP (1) EP1437354B1 (de)
JP (1) JP4101754B2 (de)
AT (1) ATE404558T1 (de)
DE (1) DE60228297D1 (de)
WO (1) WO2003029253A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745459B2 (en) 2004-09-21 2010-06-29 Japan Tobacco Inc. Quinolizinone compound and use thereof as HIV integrase inhibitor
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
WO2012047487A1 (en) * 2010-09-27 2012-04-12 Evolva Sa 2-pyridone antimicrobial compositions
EP2670410B1 (de) * 2011-02-01 2017-12-20 Emergent Product Development Gaithersburg Inc. Antimikrobielle 4-oxochinolizine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9407806A (pt) * 1993-10-14 1997-08-19 Abbott Lab Composto processo de tratamento de uma infecção bacteriana em um paciente humano ou veterinário e intermediário sintético
CA2222322A1 (en) * 1995-06-06 1996-12-12 Abbott Laboratories Quinolizinone type compounds
DE60014143T2 (de) * 1999-10-19 2006-03-02 Sato Pharmaceutical Co., Ltd. Antimikrobielle 4-oxochinolizine mit 2-pyridongerüsten als teilstruktur
WO2002022614A1 (fr) * 2000-09-12 2002-03-21 Sankyo Company,Limited Derives de quinolizine

Also Published As

Publication number Publication date
WO2003029253A1 (fr) 2003-04-10
EP1437354A4 (de) 2005-10-12
JP4101754B2 (ja) 2008-06-18
US20040229903A1 (en) 2004-11-18
JPWO2003029253A1 (ja) 2005-01-13
EP1437354B1 (de) 2008-08-13
EP1437354A1 (de) 2004-07-14
US7223773B2 (en) 2007-05-29
DE60228297D1 (de) 2008-09-25

Similar Documents

Publication Publication Date Title
CY1110442T1 (el) Παραγωγα πυριμιδινης, φαρμακα που περιεχουν τις ενωσεις αυτες, χρηση αυτων και μεθοδοι για την παρασκευη τους
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
BG66094B1 (bg) Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
BR0108374A (pt) Derivado de pirazina ou um sal deste, composição farmacêutica, e, derivado de fluoropirazina ou um sal deste
DK1322648T3 (da) 3-(heteroarylacetamido)-2-oxo-azetidin-1-sulfonsyrederivater som antibakterielle midler
WO2008143343A1 (ja) 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
CA2327775A1 (en) 15-membered lactams ketolides with antibacterial activity
DE60027015D1 (en) Pseudoerythromycin-derivate
HK1076816A1 (de)
DE69531350D1 (de) Neue chinolon- oder naphthyridoncarbonsäurederivate oder deren salze
HRP20120634T1 (hr) Antibiotik 107891, njegovi faktori, farmaceutski prihvatljive soli i sastavi, te njihova uporaba
PT984019E (pt) Carbamatos antibacterianos em c11 de macrolidos
DK1031569T3 (da) Salt af et 7-isoindolinquinoloncarboxylsyre-derivat, monohydrat deraf og sammensætning, der indeholder dette som aktiv bestanddel
ATE404558T1 (de) Antimikrobielle 4-oxochinolizinverbindungen, die als teilstruktur ein 2-pyridonskelett aufweisen
EP1251134A4 (de) Neue carbapenem-derivate als quaternäres salz
DK0808326T3 (da) Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika
DE60201921D1 (de) Kondensierte Pyrazolverbindungen
PT1338596E (pt) Processos para a preparacao de agentes antibacterianos do tipo carbapenem
TW200745053A (en) 9-Aminocarbonylsubstituted derivatives of glycylcyclines
ATE375343T1 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
KR970702244A (ko) 페넴 유도체 및 이를 함유하는 항균제(penem derivatives and antimicrobial agent containing the same)
EP1541562A4 (de) Neue uracilderivate und deren medizinische verwendung
PT897919E (pt) Novos derivados do acido piridonacarboxilico ou seus sais e agentes anti-bacterianos contendo-os como ingrediente activo
WO2008036420A3 (en) 9-(heteroaryl)-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties